• MicroVision Announces First Quarter 2021 Results

    Source: Nasdaq GlobeNewswire / 29 Apr 2021 16:05:01   America/New_York

    REDMOND, Wash., April 29, 2021 (GLOBE NEWSWIRE) -- MicroVision, Inc. (NASDAQ: MVIS), a leader in MEMS based solid state automotive lidar and micro-display technology for augmented reality, today announced its first quarter 2021 results.

    Revenue for the first quarter of 2021 was $0.5 million, compared to $1.5 million for the first quarter of 2020. MicroVision's net loss for the first quarter of 2021 was $6.2 million, or $0.04 per share, compared to a net loss of $4.9 million, or $0.04 per share for the first quarter of 2020. The Company ended the first quarter of 2021 with $75.3 million in cash and cash equivalents, compared to $16.9 million at the end of the fourth quarter of 2020.

    “We remain on track in advancing our automotive lidar development program as the Company completed its A-Sample lidar hardware and development platform on schedule,” said Sumit Sharma, Chief Executive Officer of MicroVision. “We are prepared and plan to share key performance data with potential customers, partners or parties interested in a strategic transaction. We expect that a version of this first-generation long-range lidar sensor, after internal and external validation, reliability and compliance testing, could be available for sale, in initial quantities, in the third or fourth quarter of 2021 as we previously reported. Additionally, with the recent completion of two At-the-Market equity raises, we believe the Company is in a strong financial position which enhances our ability to negotiate with potential strategic partners.”

    Financial Results Webcast

    MicroVision will host a webcast which will start at 2:00 p.m. Pacific Time on Thursday, April 29, 2021. The webcast can be accessed from the Investor Relations section of MicroVision’s website on the Investor Relations Events Calendar page at https://microvision.gcs-web.com/investor-event-calendar. Investors may submit questions for management in advance to IR@MicroVision.com or beginning 10 minutes before or during the live webcast on April 29, 2021 from the webcast link. The webcast will be available for rebroadcast from the Investor Relations section of MicroVision’s website on the Investor Relations Events Calendar page.

    About MicroVision

    MicroVision is a pioneering company in MEMS based laser beam scanning technology that integrates MEMS, lasers, optics, hardware, algorithms and machine learning software into its proprietary technology to address existing and emerging markets. The Company’s integrated approach uses its proprietary technology to provide solutions for automotive lidar sensors, augmented reality micro-display engines, interactive display modules and consumer lidar modules.

    For more information, visit the Company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc or follow MicroVision on Twitter at @MicroVision.
    MicroVision is a trademark of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

    Forward-Looking Statements  

    Certain statements contained in this release, including the Company’s future products, progress on development, pursuit of a strategic transaction, financial position and ability to negotiate with potential strategic partners and product applications and statements using words such as “plan,” “believe,” “expect” and “could” are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk that the Company may not succeed in finding licensing or other strategic solutions, including a potential sale of the Company, with acceptable timing, benefits or costs; its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements, including from the impact of COVID-19 (coronavirus); its ability to identify parties interested in paying any amounts or amounts that the Company deems desirable for the purchase or license of intellectual property assets; its or its customers’ failure to perform under open purchase orders; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain additional contract awards and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.


    MicroVision, Inc. 
    Balance Sheet 
    (In thousands) 
    (Unaudited) 
      March 31,   December 31, 
      2021   2020 
            
    Assets       
    Current Assets       
       Cash and cash equivalents$75,338  $16,862 
       Other current assets 565   698 
          Total current assets 75,903   17,560 
            
    Property and equipment, net 2,245   1,883 
    Operating lease right-of-use asset 851   946 
    Restricted cash 435   435 
    Intangible assets, net 152   164 
    Other assets 25   18 
         Total assets$79,611  $21,006 
            
            
    Liabilities and Shareholders' Equity       
    Current Liabilities       
       Accounts payable$698  $630 
       Accrued liabilities 710   495 
       Contract liabilities 7,286   7,765 
       Current portion of long-term debt 699   431 
       Current portion of operating lease liability 680   676 
       Current portion of finance lease obligations 28   31 
            Total current liabilities 10,101   10,028 
            
    Long term debt, net of current portion 886   1,151 
    Operating lease liability, net of current portion 624   774 
    Finance lease obligations, net of current portion 39   44 
            Total liabilities 11,650   11,997 
            
    Commitments and contingencies       
            
    Shareholders' Equity       
        Common stock at par value 158   153 
        Additional paid-in capital 660,267   601,224 
        Subscriptions receivable -   (6,135)
        Accumulated deficit (592,464)  (586,233)
          Total shareholders' equity 67,961   9,009 
    Total liabilities and shareholders' equity $ 79,611   $ 21,006 



    MicroVision, Inc.
    Statement of Operations
    (In thousands, except earnings per share data)
    (Unaudited)
            
            
      Three months ended March 31,
      2021   2020 
            
            
    Product revenue$-  $1,247 
    License and royalty revenue 479   212 
    Contract revenue -   10 
    Total revenue 479   1,469 
            
    Cost of product revenue (5)  1,395 
    Cost of contract revenue -   4 
    Total cost of revenue (5)  1,399 
            
       Gross margin 484   70 
            
            
    Research and development expense 4,462   3,683 
    Sales, marketing, general and administrative expense 2,247   1,771 
    Gain on disposal of fixed assets -   (450)
            Total operating expenses 6,709   5,004 
            
    Loss from operations (6,225)  (4,934)
            
    Other expense, net (6)  - 
            
    Net income (loss)$(6,231) $(4,934)
            
    Net income (loss) per share - basic and diluted$(0.04) $(0.04)
            
    Weighted-average shares outstanding - basic and diluted 155,454   127,214 

    Investor Relations Contact

    David H. Allen
    Darrow Associates, Inc.
    408.427.4463
    dallen@darrowir.com


    Primary Logo

Share on,